SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 7

İdiyopatik ve iskemik kardiyomiyopatili hastalarda ortalama trombosit hacmi düzeylerinin değerlendirilmesi: Gözlemsel bir çalışma

The evaluation of mean platelet volume levels in patients with idiopathic and ischemic cardiomyopathy: An observational study

Necip ERMİŞ
Mehmet CANSEL
Hasan PEKDEMİR
Halil ATAŞ
Nusret AÇIKGÖZ
Ramazan ÖZDEMİR
Jülide YAĞMUR
Pages
595–599
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The MPV values were significantly higher in patients with idiopathic CMP and ischemic CMP than those of the controls (9.03±1.3 and 8.77±0.9 vs. 7.95±1.0 fl, respectively, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiomyopathy (CMP) is a disorder associated with an increased risk of thromboembolism due to blood stasis, platelet activation and altered coagulation status.
📊
Key Findings & Data:A total of 100 subjects with idiopathic CMP (n=35), ischemic CMP (n=35) and controls (n=30) were included in the study.
💡
Conclusion & Impact:Results: The MPV values were significantly higher in patients with idiopathic CMP and ischemic CMP than those of the controls (9.03±1.3 and 8.77±0.9 vs. 7.95±1.0 fl, respectively, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Cardiomyopathy (CMP) is a disorder associated with an increased risk of thromboembolism due to blood stasis, platelet activation and altered coagulation status. In this study, we aimed to investigate mean platelet volume (MPV) in patients with idiopathic CMP and ischemic CMP and to compare with those of the controls, and aimed to determine whether there is a relationship between MVP and echocardiographic parameters in patients with CMP. Methods: This study was designed as an observational cross-sectional study. A total of 100 subjects with idiopathic CMP (n=35), ischemic CMP (n=35) and controls (n=30) were included in the study. The MPV values were measured in all participants. All subjects underwent transthoracic echocardiography and angiographic evaluation. We used Chi-square test, one-way ANOVA and Pearson correlation tests for statistical analysis. Results: The MPV values were significantly higher in patients with idiopathic CMP and ischemic CMP than those of the controls (9.03±1.3 and 8.77±0.9 vs. 7.95±1.0 fl, respectively, p

Özet

Amaç: Kardiyomiyopati (KMP) kan stazı, trombosit aktivasyonu ve değişen koagülasyon durumu nedeniyle, artmış tromboemboli ile ilişkili bir hastalıktır. Biz, bu çalışmada iskemik ve idiyopatik KMP’li hastalarda ortalama trombosit hacmini (OTH) belirlemeyi ve onları kontrol grubuyla kıyaslamakla birlikte, KMP’li hastalarda OTH ile ekokardiyografik parametreler arasında bir ilişki olup olmadığını da belirlemeyi amaçladık. Yöntemler: Bu çalışma gözlemsel enine-kesitli çalışma olarak dizayn edildi. Çalışmaya idiyopatik KMP’li 35 hasta, iskemik KMP’li 35 hasta ve kontrol grubu 30 kişi olmak üzere toplam 100 birey dahil edildi. Çalışmaya katılan tüm bireylerin OTH değerleri ölçüldü ve tüm katılanlara transtorasik ekokardiyografi ve anjiyografik değerlendirme yapıldı. İstatistiksel analizler için Ki-kare testi, tek yönlü ANOVA ve Pearson korelasyon testleri kullanıldı. Bulgular: Çalışmamızda OTH değeri idiyopatik ve iskemik KMP’li hastalarda kontrol grubuna göre anlamlı olarak daha yüksek bulundu (9.03±1.3‘e karşın 8.77±0.9 ve 7.95±1.0 fl, sırasıyla, p

🔖

Cite This Article

ERMİŞ, N., CANSEL, M., PEKDEMİR, H., ATAŞ, H., AÇIKGÖZ, N., ÖZDEMİR, R., YAĞMUR, J. (2022). İdiyopatik ve iskemik kardiyomiyopatili hastalarda ortalama trombosit hacmi düzeylerinin değerlendirilmesi: Gözlemsel bir çalışma. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 7, 595–599. https://ajindex.com/articles/436555

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gottdiener JS, Gay JA, VanVoorhees L, DiBianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment of 2-dimensional echocardiography. Am J Cardiol 1983
  2. [CrossRef] 2. Siostrzonek P, Koppensteiner R, Gössinger H, Zangeneh M, Heinz G, Kreiner G, et al. Hemodynamic and hemorheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1993
  3. [CrossRef] 3. Smith NM, Pathansali R, Bath PM. Platelets and stroke. Vasc Med 1999
  4. [CrossRef] 4. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991
  5. [CrossRef] 5. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002
  6. [CrossRef] 6. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2009
  7. Yamamoto K, Ikeda U, Furuhashi K, Irokawa M, Nakayama T, Shimada K. The couagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1995
  8. [CrossRef] 8. Jung SC, Wilensky RL, Zeller J. Thrombin activation in dilated cardiomyopathy. J Am Coll Cardiol 1993
  9. 21 Suppl A:311A. 9. Asinger RW, Mikell FL, Elsperger J, Hodges M. Incidence of leftventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med 1981
  10. [CrossRef] 10. Koniaris LS, Goldhaber SZ. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol 1998
  11. [CrossRef] 11. Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 1999
  12. Dotsenko O, Kakkar VV. Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications. J Thromb Haemost 2007
  13. [CrossRef] 13. Asakura H, Hifumi S, Jokaji H, Saito M, Kumabashiri I, Uotani C, et al. Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 1992
  14. [CrossRef] 14. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up